Immune Based Treatment For Influenza Read more about Immune Based Treatment For Influenza US Application 61/538,427Filed on 2011-09-23
Immune Based Treatment For Influenza Read more about Immune Based Treatment For Influenza US Application 61/490,056Filed on 2011-05-25
A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL TISSUE-SPECIFIC EXPRESSION Read more about A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL TISSUE-SPECIFIC EXPRESSION US Application 61/664,518Filed on 2012-06-26
Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine Read more about Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine US Application 61/661,209Filed on 2012-06-18
NEUTRALIZING GP41 ANTIBODIES AND THEIR USE Read more about NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US Application 61/672,708Filed on 2012-07-17
HIV-Neutralizing Polypeptides And Methods Of Their Use. Read more about HIV-Neutralizing Polypeptides And Methods Of Their Use. US Application 61/649,150Filed on 2012-05-18
Novel Attenuated Vaccine Read more about Novel Attenuated Vaccine US Application 61/753,320Filed on 2013-01-16
A Formulation Of Mycobacterial Components As An Adjuvant For Inducing Th17 Response Read more about A Formulation Of Mycobacterial Components As An Adjuvant For Inducing Th17 Response US Application 61/709,713Filed on 2012-10-04